Header Logo

Connection

Mark Lang to Antigens, CD1

This is a "connection" page, showing publications Mark Lang has written about Antigens, CD1.
Connection Strength

1.956
  1. CD1d-dependent CLL progression? Blood. 2017 06 29; 129(26):3398-3399.
    View in: PubMed
    Score: 0.574
  2. Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production. Blood. 2008 Feb 15; 111(4):2158-62.
    View in: PubMed
    Score: 0.296
  3. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Immunology. 2006 Sep; 119(1):116-25.
    View in: PubMed
    Score: 0.267
  4. Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis? Infect Immun. 2006 Feb; 74(2):803-9.
    View in: PubMed
    Score: 0.260
  5. BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments. Int Immunol. 2005 Jul; 17(7):899-908.
    View in: PubMed
    Score: 0.249
  6. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts. Immunology. 2004 Jul; 112(3):386-96.
    View in: PubMed
    Score: 0.233
  7. Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers. Eur J Immunol. 2008 Apr; 38(4):1001-11.
    View in: PubMed
    Score: 0.076
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.